Novo Nordisk, Eli Lilly and White House
Digest more
Novo Nordisk once dominated the weight-loss drug market with Wegovy. However, rising competition, particularly from Eli Lilly ...
Wegovy-maker Novo Nordisk lowered its full-year profit and sales forecast on Wednesday in an early blow to the Danish drugmaker's new CEO while it strives to claw back lost ground in a fierce obesity ...
1don MSN
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors ...
Record performance of its GLP-1 drugs sent shares in Eli Lilly soaring almost 4% after its earnings call on Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results